Doxa is a Swedish-based dental company, marketing, selling and developing dental bioceramic products.

Ceramir® Crown & Bridge, the first in a range of planned bioceramic dental products from Doxa, is an advanced dental cement used for the permanent fixture of dental crowns and bridges.

Company History

2010
"New Product Innovation 2010" awarded to Doxa by Frost & Sullivan.
Exclusive distribution agreement with AB Nordenta for the Swedish market.

2009
Introduction of the dental cement Ceramir® Crown & Bridge in Sweden.
Doxa re-structured from R&D company to a dental marketing and sales company

2008
FDA approval of XeraCem®.
CE approval of XeraCem®.
Successful clinical studies with XeraCem®.

2007
Successful clinical studies with Xeraspine®, Doxa's product for vertebral compression fractures, using percutaneous vertebroplasty as well as kyphoplasty

2006
CE approval of Xeraspine®

2005
Successfully completed clinical studies of Xeraspine®

2003
CE approval of second generation dental restorative

2002
FDA approval of dental restorative

2001
ISO certification.

2000
CE approval of first generation dental restorative

1999
Prototype dental restorative

1987
Doxa founded